Immunology Investor Event slide image

Immunology Investor Event

Dupixent: Chronic Inducible Urticaria (Cold) Number of patients (thousands) Prevalence(1) Biologic eligible 25 0 20 20 Source: Sanofi analysis (1) 12+ population 15 Immunology Investor Event 40 40 60 60 160 80 80 US sanofi Refractory to antihistamines 100 120 140 160 180
View entire presentation